Tülay Şahin1, Aylin Ayyildiz, Kardelen Gencer-Atalay, Cem Akgün, Haci Mustafa Özdemir, Banu Kuran. 1. From the Division of Pain Medicine, Department of Physical Medicine and Rehabilitation, Science Health University, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey (TŞ); Department of Physical Medicine and Rehabilitation, Science Health University, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey (AA, BK); Physical Medicine and Rehabilitation Department, Marmara University Medical Faculty, Istanbul, Turkey (KG-A); Department of Neurosurgery, Science Health University, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey (CA); and Department of Orthopedics and Traumatology, Science Health University, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey (HMÖ).
Abstract
OBJECTIVE: The clinical manifestations of COVID-19 range from mild symptoms to severe pneumonia and severe organ damage. When evaluated specifically for pain, the data so far have shown that myalgia, headache, and chest pain can be seen in patients at varying rates; myalgia and headache, especially, are among the initial symptoms. DESIGN: This retrospective chart review, followed by a descriptive survey design study, was carried out by examining patients afflicted with COVID-19. After discharge, patients were asked about the severity and the body region of their pain, their use of analgesics, their mood and mental health, and their overall quality of life. RESULTS: A total of 206 patients with a mean age of 56.24 ± 16.99 yrs were included in the study. Pain during COVID-19 was found to be higher compared with the preinfectious and postinfectious states. The most frequent painful areas were reported to be the neck and back before the infection, whereas the head and limbs during the infection. The most frequently used analgesic during infection was paracetamol. There was no relationship between the patients' pain and anxiety and depression; the quality of life was found to be worse in patients with persistent pain. CONCLUSIONS: This study showed that the head and limbs were the most common painful body regions during COVID-19. It was also found that pain can continue in the postinfection period.
OBJECTIVE: The clinical manifestations of COVID-19 range from mild symptoms to severe pneumonia and severe organ damage. When evaluated specifically for pain, the data so far have shown that myalgia, headache, and chest pain can be seen in patients at varying rates; myalgia and headache, especially, are among the initial symptoms. DESIGN: This retrospective chart review, followed by a descriptive survey design study, was carried out by examining patients afflicted with COVID-19. After discharge, patients were asked about the severity and the body region of their pain, their use of analgesics, their mood and mental health, and their overall quality of life. RESULTS: A total of 206 patients with a mean age of 56.24 ± 16.99 yrs were included in the study. Pain during COVID-19 was found to be higher compared with the preinfectious and postinfectious states. The most frequent painful areas were reported to be the neck and back before the infection, whereas the head and limbs during the infection. The most frequently used analgesic during infection was paracetamol. There was no relationship between the patients' pain and anxiety and depression; the quality of life was found to be worse in patients with persistent pain. CONCLUSIONS: This study showed that the head and limbs were the most common painful body regions during COVID-19. It was also found that pain can continue in the postinfection period.
Authors: Giuseppe Francesco Papalia; Giorgia Petrucci; Fabrizio Russo; Luca Ambrosio; Gianluca Vadalà; Sergio Iavicoli; Rocco Papalia; Vincenzo Denaro Journal: Int J Environ Res Public Health Date: 2022-04-11 Impact factor: 4.614
Authors: Antimo Moretti; Antonella Belfiore; Massimiliano Bianco; Sara Liguori; Marco Paoletta; Giuseppe Toro; Francesca Gimigliano; Giovanni Iolascon Journal: J Int Med Res Date: 2022-09 Impact factor: 1.573